In this era of global health crisis due to COVID-19, the challenges have been numerous and the unpredictability of the pandemic has been a real issue. However, the past year has been an opportunity for the Cancer Research Society to demonstrate resilience, adaptability and innovation.
Faced with adversity, we are coming out of this crisis stronger and more determined than ever to outsmart cancer.
Moreover, in 2020-2021, the Society funded 160 projects dedicated to cancer research, with a combined value of close to $10 million.
Despite a year in of COVID-19 restrictions, the cancellation of all in-person fundraising activities and the need to reinvent ourselves, the Society was able to not only fulfill its mission, but also seize the opportunity to review some of its internal processes with a view of enhancing its performance. The fact that revenues considerably increased in spite of it all is certainly an achievement.
Funding cancer research is at the very heart of our mission; it is our raison d’être as an organization. The impact of the funds we raise is significant.
